PHARMACOLOGICAL CLASSIFICATION: A24 Mineral substitutes, electrolytes.
PHARMACOLOGICAL ACTION: Magnesium supplement in the treatment of hypomagnesemia and magnesium deficiencies.
INDICATIONS: For prophylactic and therapeutic treatment of disorders arising from imbalance and deficiency of magnesium.
CONTRA-INDICATIONS: Renal impairment; acute dehydration and gastric lesions and disorders.
DOSAGE AND DIRECTIONS FOR USE: According to the individual needs of the patient.
Prophylactic dose:
2 or 4 tablets daily in divided doses.
Therapeutic dose:
2 - 6 tablets daily in divided doses
SIDE-EFFECTS AND SPECIAL PRECAUTIONS: Mild forms of diarrhoea and bowel discomfort may occur. Occasionally nausea is reported. Slow-Mag® is generally well tolerated.
KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENT: Gastrointestinal discomfort in mild cases may be treated by discontinuing the drug and increasing fluid intake. Unusual overdoses by the oral route are not recorded but could give rise to renal failure, reduced tendon reflexes and respiratory paralysis. This situation could be countered by intravenous fluid therapy using K, Na, and Ca electrolyte replacement solutions and monitoring the situation clinically. Where the magnesium is still present in the gastro-intestinal tract, suitable ion exchange therapy may be instituted.
PRESENTATION: Slow-Mag® is supplied in bottles of 30, 60 and 100 tablets.
STORAGE INSTRUCTIONS: Store below 25°C in a dry place, away from sunlight and heat.
Keep out of reach of children.
REGISTRATION NUMBER: H/24/89
NAME AND BUSINESS ADDRESS OF THE APPLICANT:
Merck (Pty) Limited Reg. No. 1970/004059/07
1 Friesland Drive
Longmeadow Business Estate
Modderfontein, 1645
DATE OF PUBLICATION OF THIS PACKAGE INSERT: 12 November 1975
® = Registered Trade Mark
F70472
P03/03 Highland Print
Updated on this site: May 2004
Source: Community Pharmacy
SLOW-MAG® Tablets